Nautilus Biotechnology to Participate in Upcoming September Investor Conferences
Provided By GlobeNewswire
Last update: Aug 27, 2025
SEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the following investor conferences.
Read more at globenewswire.com
